Delivery Order SPE2DR25D1002-SPE2DR26FGM2S
- Not listed
- The Defense Logistics Agency awarded a $1,123.46 delivery order to AmerisourceBergen Drug Corp on January 2, 2026, for the supply of Isotretinoin 30 mg capsules (30-count units), with completion scheduled for January 5, 2026. This competitive award, utilizing firm fixed pricing, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work will be...
- The Defense Logistics Agency awarded a delivery order valued at $2,868.79 to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count units) on September 15, 2025, with completion scheduled for September 16, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with DLA. The work will be performed at the contractor's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Isotretinoin 30 mg capsules (30-count units) valued at $1,153.95, with a firm fixed price structure and ultimate completion date of September 23, 2025. This competitively awarded, non-set-aside contract represents a continuation order under AmerisourceBergen's existing pharmaceutical supply agreements with DLA. The work will be performed at the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count units) valued at $8,013.86. The contract was executed on October 30, 2025, with an ultimate completion date of October 31, 2025, and employs firm fixed pricing with no set-aside designation. Performance will occur at AmerisourceBergen Drug Corp's Corporate Office location in Conshohocken, Pennsylvania, reflecting the company's role as a major pharmaceutical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,269.27 for 30 mg Isotretinoin capsules (30-count supply) with an ultimate completion date of November 17, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award status. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,578.20 to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (10-count units) on November 18, 2025, with an ultimate completion date of November 19, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Isotretinoin 30 mg capsules in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $1,915.32, with an ultimate completion date of December 9, 2025. The award was not set aside and represents a competitive award to the prime contractor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the location of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules in quantities of 30 units, with a ceiling value of $3,639.64. This award, issued on December 31, 2025, with an ultimate completion date of January 2, 2026, represents a firm fixed-price delivery order with no set-aside designation, indicating the contract was competitively awarded. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $5,430.50 to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count package), with an ultimate completion date of November 26, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price pricing and represents a child order under AmerisourceBergen's broader pharmaceutical supply framework. The delivery will be performed at the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count) with a ceiling value of $2,464.20. This is a firm fixed-price, non-set-aside delivery order awarded on October 22, 2025, with an ultimate completion date of October 23, 2025. The order is being fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate headquarters. This delivery order is issued...
- SPE2DR25D1002Indefinite Delivery Contract
- SPE2DR25D1002-SPE2DR26FGM2SDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count units) under a firm fixed-price contract valued at $1,567.38. The contract was awarded on January 2, 2026, with an ultimate completion date of January 5, 2026, and represents a non-set-aside competitive award. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive pharmaceutical prime vendor contract enables AmerisourceBergen to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare systems worldwide. The delivery order for Isotretinoin—an oral medication used primarily in dermatological treatment—exemplifies the routine pharmaceutical procurement conducted under this master contract vehicle to support Department of Defense and veteran healthcare requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 1/1/26 |